Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (IGF-1)

Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (IGF-1)

US Patent 9587024 · Granted Mar 7, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antigen binding regions against fibronectin type III domains and methods of usin2025
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof2025
Antibody specific for CD22 and methods of use thereof2024
Anti-kit antibodies and uses thereof2024
Anti-kit antibodies and uses thereof2024
Chimeric antigen receptor system with adaptable receptor specificity2024
Anti-MET antibodies and methods of use thereof2024
Anti-MET antibodies and methods of use thereof2024
Humanized antibodies against CEACAM12024
Humanized antibodies against CEACAM12024
Polypeptides comprising a modified bacteriophage G3P amino acid sequence lacking2023
Polypeptides comprising a modified bacteriophage G3P amino acid sequence lacking2023